Trade Summary

3 days ago, Finley John David, serving as CEO, CFO at PALISADE BIO, INC. (PALI), sold 146,798 shares at $2.07 per share, for a total transaction value of $303,343.39. Following this transaction, Finley John David now holds 217,555 shares of PALI.

This sale represents a 40.29% decrease in Finley John David's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 7, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 8, 2026 at 6:49 PM ET, 1 day after the trade was made.

PALISADE BIO, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.